期刊中文名:生物工程ISSN:2306-5354
該(gai)雜志(zhi)(zhi)國際簡稱:Bioengineering,是(shi)由(you)出版商(shang)Multidisciplinary Digital Publishing Institute (MDPI)出版的(de)(de)一本(ben)致力于發布醫學(xue)(xue)研(yan)究(jiu)新(xin)成果(guo)的(de)(de)的(de)(de)專(zhuan)業學(xue)(xue)術期刊。該(gai)雜志(zhi)(zhi)以ENGINEERING, BIOMEDICAL研(yan)究(jiu)為(wei)重(zhong)點,主要發表(biao)刊登有創見的(de)(de)學(xue)(xue)術論文(wen)文(wen)章、行業最新(xin)科研(yan)成果(guo),扼要報道階(jie)段性研(yan)究(jiu)成果(guo)和重(zhong)要研(yan)究(jiu)工作的(de)(de)最新(xin)進展(zhan),選載對學(xue)(xue)科發展(zhan)起指導(dao)作用的(de)(de)綜述與(yu)專(zhuan)論,促進學(xue)(xue)術發展(zhan),為(wei)廣大讀者服務(wu)。該(gai)刊是(shi)一本(ben)國際優秀雜志(zhi)(zhi),在(zai)國際上有很高(gao)的(de)(de)學(xue)(xue)術影響力。
《Bioengineering》是一(yi)本(ben)以English為主(zhu)的開放獲(huo)取國際(ji)優秀(xiu)期刊(kan),中文名稱生(sheng)物(wu)工程,本(ben)刊(kan)主(zhu)要出版、報道醫學(xue)-ENGINEERING, BIOMEDICAL領(ling)域的研究動(dong)態以及(ji)在該(gai)領(ling)域取得的各方(fang)面的經驗和科(ke)研成果,介紹該(gai)領(ling)域有(you)關本(ben)專(zhuan)業(ye)的最新進展(zhan),探(tan)討行(xing)業(ye)發(fa)展(zhan)的思路(lu)和方(fang)法,以促進學(xue)術信息交流,提高行(xing)業(ye)發(fa)展(zhan)。該(gai)刊(kan)已被國際(ji)權(quan)威數(shu)據庫SCIE收錄,為該(gai)領(ling)域相關學(xue)科(ke)的發(fa)展(zhan)起到(dao)了良好(hao)的推(tui)動(dong)作(zuo)用,也得到(dao)了本(ben)專(zhuan)業(ye)人員的廣泛認(ren)可。最新CiteScore 指(zhi)數(shu)為4。
本刊近期中國學者發表的(de)論文主要(yao)有:
Author: Zou, Li; Chu, Kisum; He, Xuan; Li, Ye; Zhou, Liangbin; Xu, Xiayi; Liao, Wei-Hsin; Qin, Ling
Author: Zhao, Yanli; Fu, Chong; Zhang, Wenchao; Ye, Chen; Wang, Zhixiao; Ma, Hong-feng
Author: Zhang, Rui; Zhao, Liangliang; Kong, Qingrui; Yu, Guolong; Yu, Haibin; Li, Jing; Tai, Wei-Hsun
Author: Wang, Ye; Wei, Yongsheng; Liao, Hui; Fu, Hongwei; Yang, Xiaobin; Xiang, Qi; Zhang, Shu
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering
2023年12月升級(ji)版 |
綜述:否
TOP期刊:否
大類:醫學 3區
小類:
ENGINEERING, BIOMEDICAL |
2022年12月(yue)升級版 |
綜述:否
TOP期刊:否
大類:工程技術 3區
小類:
ENGINEERING, BIOMEDICAL |
中科院SCI分區:是(shi)中國科(ke)學院(yuan)(yuan)文獻情報中心(xin)科(ke)學計量(liang)中心(xin)的科(ke)學研究成果。期(qi)刊(kan)(kan)分區(qu)(qu)(qu)表(biao)自(zi)2004年(nian)開始發(fa)布(bu),延續至今;2019年(nian)推(tui)出升級版(ban),實現基(ji)礎(chu)版(ban)、升級版(ban)并存過渡,2022年(nian)只發(fa)布(bu)升級版(ban),期(qi)刊(kan)(kan)分區(qu)(qu)(qu)表(biao)數據每年(nian)底發(fa)布(bu)。 中科(ke)院(yuan)(yuan)分區(qu)(qu)(qu)為(wei)(wei)4個區(qu)(qu)(qu)。中科(ke)院(yuan)(yuan)分區(qu)(qu)(qu)采(cai)用刊(kan)(kan)物前(qian)3年(nian)影響因子平均值進行分區(qu)(qu)(qu),即前(qian)5%為(wei)(wei)該類1區(qu)(qu)(qu),6%~20%為(wei)(wei)2區(qu)(qu)(qu)、21%~50%為(wei)(wei)3區(qu)(qu)(qu),其余的為(wei)(wei)4區(qu)(qu)(qu)。1區(qu)(qu)(qu)和2區(qu)(qu)(qu)雜志很少(shao),雜志質(zhi)量(liang)相對也高,基(ji)本都是(shi)本領域(yu)的頂(ding)級期(qi)刊(kan)(kan)。
按JIF指標學(xue)科分區 |
JCR分區:JCR分(fen)(fen)區來(lai)自科睿(rui)唯安公司,JCR是一(yi)個(ge)獨(du)特的(de)多學(xue)科期(qi)刊評(ping)價(jia)工具,為唯一(yi)提供基(ji)于引文數(shu)據的(de)統計信息(xi)的(de)期(qi)刊評(ping)價(jia)資源。每年(nian)發布(bu)的(de)JCR分(fen)(fen)區,設置了(le)254個(ge)具體學(xue)科。JCR分(fen)(fen)區根據每個(ge)學(xue)科分(fen)(fen)類按照期(qi)刊當年(nian)的(de)影響因子高低將(jiang)期(qi)刊平均分(fen)(fen)為4個(ge)區,分(fen)(fen)別為Q1、Q2、Q3和(he)Q4,各占(zhan)25%。JCR分(fen)(fen)區中期(qi)刊的(de)數(shu)量是均勻分(fen)(fen)為四個(ge)部分(fen)(fen)的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Chemical Engineering 小類:Bioengineering | Q3 | 104 / 162 |
36% |
該(gai)(gai)雜志(zhi)是(shi)一本(ben)國際(ji)優秀雜志(zhi),在(zai)(zai)國際(ji)上有(you)較高的學(xue)術影響力,行業關(guan)注度(du)很高,已被國際(ji)權威數(shu)據庫SCIE收錄,該(gai)(gai)雜志(zhi)在(zai)(zai)ENGINEERING, BIOMEDICAL綜合專(zhuan)業領域專(zhuan)業度(du)認可很高,對稿(gao)(gao)(gao)件內容的創(chuang)新性和學(xue)術性要求很高,作為一本(ben)國際(ji)優秀雜志(zhi),一般投稿(gao)(gao)(gao)過審時(shi)間(jian)都較長(chang),投稿(gao)(gao)(gao)過審時(shi)間(jian)平均 first decision approximately 15.9 days after submission; acceptance to publication is undertaken in 3.7 days ,如果想投稿(gao)(gao)(gao)該(gai)(gai)刊要做好時(shi)間(jian)安排。版面費不(bu)祥。該(gai)(gai)雜志(zhi)近兩年未被列(lie)入預警名(ming)單(dan),建議您投稿(gao)(gao)(gao)。如您想了解更多(duo)投稿(gao)(gao)(gao)政策及(ji)投稿(gao)(gao)(gao)方案,請咨(zi)詢客服。
若用戶需要出(chu)版(ban)服務,請聯系(xi)出(chu)版(ban)商:MDPI, ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052。
RESPIRATORY SYSTEM
中科院 3區
INTEGRATIVE & COMPLEMENTARY MEDICINE
中科院 2區
ONCOLOGY
中科院 2區
DENTISTRY, ORAL SURGERY & MEDICINE
中科院 2區
GASTROENTEROLOGY & HEPATOLOGY
中科院 4區
HEALTH CARE SCIENCES & SERVICES
中科院 4區
PHARMACOLOGY & PHARMACY
中科院 2區
HEALTH CARE SCIENCES & SERVICES
中科院 3區